Early outcome after intravenous thrombolysis in patients with acute ischemic stroke

Neurology India

Volumn 59, Issue 3, 2011, Pages 351-354

  Dharmasaroja, Pornpatr A ^a   Muengtaweepongsa, Sombat ^a   Dharmasaroja, Permphan ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Mahidol University   (Thailand)

Author keywords

Asia; outcome; stroke; Thai; thrombolysis

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RATING SCALE; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGE FACTORS; AGED; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 80052251745     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.82723     Document Type: Article

References (17)

1. The national institute of neurological disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Blinzler C, Breuer L, Huttner HB, Schellinger PD, Schwab S, Kohrmann M. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke. Cerebrovasc Dis 2011;31:185-90.
3. Muresan IP, Favrole P, Levy P, Andreux F, Marro B, Alamowitch S. Very early neurologic improvement after intravenous thrombolysis. Arch Neurol 2010;67:1323-8.
4. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. American Heart Association Stroke Council: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American heart association/American stroke association. Stroke 2009;40:2945-8.
5. Hacke W, Kaste M, Fiesche C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998;352:1245-51. (Pubitemid 28470336)
6. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000;31: 1812-6. (Pubitemid 30620455)
7. Delgado MG, Michel P, Naves M, Maeder P, Reichhart M, Wintermark M, et al. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population. J Neurol Neurosurg Psychiatry 2010;81:282-5.
8. Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, et al. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: A hospital-based study from south India. Neurol India 2010; 58:403-6.
9. Karepov VG, Gur AY, Bova I, Aranovich BD, Bornstein NM. Stroke in evolution: Infarct-inherent mechanisms versus systemic causes. Cerebrovasc Dis 2006;21:42-6. (Pubitemid 43110309)
10. Caplan LR. Worsening in ischemic stroke patients: Its time for a new strategy? Stroke 2002;33:1443-5.
11. Kario K, Matsuo T, Hoshide S, Schwartz JE, Shimada K, Pickering TG. Stroke prognosis of abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001;38:852-7. (Pubitemid 34258682)
12. Steinke W, Ley SC. Lacunar stroke is the major cause of progressive motor deficits. Stroke 2002:33;1510-6. (Pubitemid 34619949)
13. Schweitzer JR, Koehler PJ, Voogd AC, Franke CL. Searching for prognostic variables for secondary worsening after ischemic stroke. J Neurol 2010;257:1552-6.
14. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, et al. CLOBUST Investigators. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment. A multicenter transcranial Doppler study. Stroke 2007;38:69-74.
15. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, et al. Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke 2001;32:661-8.
16. Aronowski J, Strong R, Grotta JC. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 1997;17:1048-56. (Pubitemid 27459332)
17. Baird AE, Benfield A, Schlaug G, Siewert B, Lovlad KO, Edelmann RR, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic. Ann Neurol 1997;41:581-9. (Pubitemid 27212651)